Meta AnalysisID 3874

局部毛果芸香碱治疗老视的有效性与安全性:一项系统评价

CRD42022307256

Is topical Pilocarpine is effective in treatment of presbyopia? What is its safety profile?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
3874
Evidence Id
12432
Core Evidence Id
12432
Source Meta Analysis Id
3831
Herb2 Meta Analysis Id
HBMA003831
Crd Id
CRD42022307256
Title
Efficacy and safety of topical pilocarpine in the management of presbyopia: A systematic review
Review Question
Is topical Pilocarpine is effective in treatment of presbyopia? What is its safety profile?
Study Type Included
1. Studies including diagnosed presbyopic patients in which topical Pilocarpine has been used as treatment modality and pre and post drug application have been documented. 2. Observational studies of any type (prospective, retrospective, cohort), case series with ≥ 5 cases.
Condition Being Studied
Presbyopia patients of all age group 40-60 year in which topical Pilocarpine is used as treatment modality
Participant
Presbyopia patients of all age group 40-60 year in which topical Pilocarpine is used as treatment modality.
Animal
Human Disease Modelled
Intervention
Intervention: topical pilocarpine solution Inclusion criteria: 1. Patients including ≥ 40 year age less than 60 years old 2. Only patients with UNVA of at least Jaeger 2 or worse reading performance were included 3. Observational studies of any type, case series with ≥5 cases. Exclusion criteria: 1. Studies with baseline imbalance 2. Case report and case series less than 5 cases
Comparator Control
1. Pre and post data after application of Pilocarpine 2. Pilocarpine vs. placebo
Main Outcome
1. Near visual acuity (Uncorrected and corrected) (Jegger 1 and Jegger 2) 2. Distant visual acuity (Uncorrected and corrected) Measures of effect Continuous data: mean difference with 95% C.I will be calculated. For dichotomous data: Risk ratio will be calculated (95% C. I.)
Outcome Measure
Additional Outcome
Intra ocular pressure (IOP), treatment emergent adverse event (TEAEs) and Patient satisfaction level Measures of effect For absolute change mean difference (MD) and 95% confidence interval (CI) will be calculated. On the other hand, risk ratio will be calculated for dichotomous data.
Study Method
Intervention, Prevention, Systematic review
Keyword
Humans; Pilocarpine; Presbyopia
Contact
ANUSUYA BHATTACHARYYA [email protected]
Organisational Affiliation
GMCH 32, Chandigarh www.gmch.gov.in
Funding Source
nil. self funded Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> NA
Other Selection Criteria
Final Publication
Same Topic Review
Nil
Published Protocol
Review Type
Language
English
Country
India
Review Stage
Review Ongoing
First Submission Date
2022-08-09
Registration Date
2022-08-20
Anticipated Start Date
2022-08-09
Anticipated Completion Date
2022-10-10
Title Cn
局部毛果芸香碱治疗老视的有效性与安全性:一项系统评价
Title En
Efficacy and safety of topical pilocarpine in the management of presbyopia: A systematic review
Bilingual Status
complete